LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) today announced that it will request a hearing before the NASDAQ Listing Qualifications Panel in response to the receipt of a NASDAQ Staff Determination Letter indicating that the company is not in compliance with Marketplace Rule 4310(c)(14), which requires timely filing of periodic reports with NASDAQ for continued listing. As anticipated, the letter was issued in accordance with NASDAQ’s procedures as a result of the delayed filing of the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.
